Watch Thursday 5.14.20 7a PST/10aEST
https://www.c-span.org/video/?471986-1/dr-rick-bright-testifies-coronavirus-pandemic-response
Dr. Rick Bright Testimony on Coronavirus Pandemic Response
Dr. Rick Bright, the recent director of the Biomedical Advanced Research and Development Authority who says he was removed from his job, testified before a House Energy and Commerce subcommittee.
KELLY: Tell us a little bit more about Rick Bright. I know you have read his complaint, all 63 pages of it, and you have verified a lot of it. Give us the gist.
DIAMOND: Rick Bright, who was abruptly transferred about three weeks ago to a smaller role at the National Institutes for Health, has alleged that his transfer was politically motivated, that he had been raising concerns for months about the Trump administrationās problematic response to the COVID-19 outbreak. Some of his concerns were about supplies, about not enough masks. And I think his warnings have been borne out. The U.S. was caught flat-footed. And had the U.S. followed some of the concerns that Dr. Bright was raising and acted on them, we wouldāve been in a better position.
KELLY: He was also one of the ones raising concerns about the malaria drug that President Trump was trumpeting for a while there as a possible way out of all this, right?
DIAMOND: Thatās right. Thatās right. And thatās really the crux of his complaint and what I was trying to get to the bottom of. Dr. Bright says that he was the one helping block efforts to make that malaria drug widely available despite scant evidence that it would be effective for COVID-19.
KELLY: OK.
DIAMOND: Itās not clear, though, that he went as far as his allegations suggest that he did. And thereās some evidence that he may have actually been more favorable to using the drug than Dr. Bright alleged in his complaint.
KELLY: Right. I mean, you have found as you reported this out - youāve interviewed a bunch of people. You have found, as one often does, that itās complicated. What are some of the people saying who question some of Rick Brightās claims?
DIAMOND: Well, I think there are two areas, Mary Louise. One would be that Dr. Bright, while certainly not the biggest fan of using these malaria drugs, did help make it possible for the federal government to acquire them in the first place. He did play a role. He did not lie in the road and stop that project from moving forward.
I think a second issue is that Dr. Bright and his ouster - that was months in the making. I, as a political reporter, cover the agency pretty closely, and I talked to officials dating back to last year about frustrations with Dr. Bright and plans to move him early this year, even before we knew that COVID-19 was on the horizon.